+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID06819774

Phase III Study of Cetirizine Hydrochloride Injection for Treating Acute Urticaria Randomized, Double-Blind, Controlled Multicenter Trial

Led by Shandong New Time Pharmaceutical Co., LTD · Updated on 2025-02-11

284

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of cetirizine hydrochloride injection compared to diphenhydramine hydrochloride injection in treating acute urticaria, which involves sudden wheals andor angioedema lasting up to six weeks. This is a randomized, double-blind, positive-controlled Phase III clinical study sponsored by Shandong New Time Pharmaceutical Co., LTD aimed at improving treatment options for this condition. Participants receive a single dose of either cetirizine hydrochloride injection administered by intravenous push along with a simulated diphenhydramine injection by deep intramuscular injection, or diphenhydramine hydrochloride injection by deep intramuscular injection with a simulated cetirizine injection by rapid intravenous injection. These treatments are designed to mimic single administrations in two study arms for comparison. During the study, participants severity of itching pruritus is scored two hours after treatment completion. Researchers monitor safety and efficacy closely, with assessments including symptom severity scores and adverse event tracking. The study enrolls adults aged 18 to 65 with acute urticaria and continues until August 2025, providing careful observation of treatment effects and participant health throughout the trial.

CONDITIONS

Brief Title

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here